January 2018

Working Toward Quality Compounded Drugs: A Critical Partnership

This week Congress will hold an important and timely hearing on compounded drugs. The hearing brings stakeholders together to reflect on a law enacted nearly five years ago in response to serious public health incidents. In 2012, a nationwide fungal meningitis outbreak originating from contaminated injectable compounded sterile drugs sickened over 750 individuals and resulted in the deaths of more than 70.

Share

Opioid Crisis: USP’s Comments to the FDA

As government agencies consider solutions to the growing opioid crisis, the Food and Drug Administration (FDA) recently sought public comment about ways to best address this national emergency. USP was pleased to provide our perspective about how public standards might help support the agency’s efforts, and to report on our recent discussions with stakeholders and the standards being considered by USP’s Healthcare Quality Expert Committee.  

Share

Protecting Medicines Quality in Africa: USP presents at 3rd Biennial Scientific Conference on Medical Products Regulation

Protecting Medicines Quality in Africa

Countries throughout Africa are working to harmonize standards to make processes more efficient and help bring needed pharmaceuticals to market, while protecting medicines quality. Learn more

Share

Ensuring Food Safety and Authenticity

The threat of food fraud is a growing concern because increasingly complex global food supply chains create numerous opportunities for fraudsters. This article discusses the challenges faced by stakeholders, and how to prevent these issues before they arise. 

Tags: Food
Share

Looking ahead in China: Celebrating 10 years, promise for the future

There’s something about an anniversary that inspires me to look to the future as well as appreciate the past, especially at the start of a new year.  As we mark the anniversary of the 10th year of USP-China, the future and the past offer a great deal to appreciate.

Tags: China
Share